All Updates

All Updates

icon
Filter
Partnerships
Meatable partners with Esco Aster to produce cultivated pork
Cell-cultured Meat
Oct 11, 2022
This week:
Funding
EKORE raises EUR 1.3 million (~ USD 1 million) in seed funding to strengthen platform
Digital Twin
Yesterday
Funding
Culina Health raises USD 7.9 million in Series A funding to expand offerings and expand team
Functional Nutrition
Dec 19, 2024
FDA approval
ViGeneron receives IND clearance for VG801 gene therapy
Cell & Gene Therapy
Dec 19, 2024
Product updates
Reflex Aerospace ships first commercial satellite SIGI
Next-gen Satellites
Dec 19, 2024
Partnerships
Vast partners with SpaceX for two private astronaut missions to ISS
Space Travel and Exploration Tech
Dec 19, 2024
Management news
Carbios appoints Philippe Pouletty as interim CEO amid plant delay
Waste Recovery & Management Tech
Dec 19, 2024
Funding
BlueQubit raises USD 10 million in seed funding to develop quantum platform
Quantum Computing
Dec 19, 2024
FDA approval
Arbor Biotechnologies receives FDA clearance for ABO-101 IND application
Human Gene Editing
Dec 19, 2024
Funding
Partnerships
Personalis partners with Merck and Moderna for cancer therapy development and investment
Precision Medicine
Dec 19, 2024
Partnerships
COTA partners with Guardant Health to develop clinicogenomic data solutions for cancer research
Precision Medicine
Dec 19, 2024
Cell-cultured Meat

Cell-cultured Meat

Oct 11, 2022

Meatable partners with Esco Aster to produce cultivated pork

Partnerships

  • Dutch cell-cultured meat producer Meatable announced a partnership with contract development and manufacturing organization (CDMO) Esco Aster for its international expansion efforts to Singapore.

  • Through the partnership, the companies will develop cultivated pork products (dumplings and sausages) on a small scale by 2024, aimed at food service outlets with supermarket expansion planned for 2025.

  • The development team claims the new products will have a similar structure, texture, juiciness, and pork flavor to that of conventional pork.

  • AnalystQuickTake: In 2021, Esco Aster received approval for its bioprocessing platform “AsterMavors” which is claimed to shorten the development cycle and eliminate the need for a pilot plant. Leveraging this technology with Meatable’s proprietary Opti-ox technology for cultivated pork production can enable companies to produce cultivated products quickly and cost-effectively. On other developments for Meatable, it has also partnered with Royal DSM for cost-effective growth media and plans to enter the German market prior to 2025.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.